Evidence method
Level · gp.fundamentals.debt_to_revenue
89.07% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ANIP · Dec 31, 2020
ANI PHARMACEUTICALS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001023024-21-000007General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
2.94% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
7.32% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
0.93% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
29.17% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
58.19% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-7.68% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
7.68% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
6.21% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History49 statesSelf-history eligible
Sep 30, 20218/8 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 354.76%
- Current
- 89.07%
- Delta
- -265.69%
- Previous
- 3.32%
- Current
- 2.94%
- Delta
- -0.38%
- Previous
- -3.05%
- Current
- 7.32%
- Delta
- 10.37%
- Previous
- 3.20%
- Current
- 0.93%
- Delta
- -2.27%
- Previous
- 111.73%
- Current
- 29.17%
- Delta
- -82.57%
- Previous
- 62.03%
- Current
- 58.19%
- Delta
- -3.83%
- Previous
- 5.29%
- Current
- -7.68%
- Delta
- -12.97%
- Previous
- 5.55%
- Current
- 7.68%
- Delta
- 2.13%
- Previous
- 4.50%
- Current
- 6.21%
- Delta
- 1.71%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · ANIP Fundamental State →Transitioned To · ANIP Fundamental State →Transitioned To · ANIP BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · ANIP CAPEX_INTENSITY_DECREASED →Transitioned To · ANIP CASH_GENERATION_INCREASED →Transitioned To · ANIP GROWTH_DECREASED →Transitioned To · ANIP INVENTORY_PRESSURE_DECREASED →Transitioned To · ANIP MARGIN_DECREASED →Transitioned To · ANIP PROFITABILITY_DECREASED →Transitioned To · ANIP R_AND_D_INTENSITY_INCREASED →Transitioned To · ANIP SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.